ASHBURN, VA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)AMERICAN COLLEGE OF CLINICAL PHARMACOLOGY INC, founded in 1969, is a community nonprofit that reported $2.5M in total revenue in fiscal year 2024. Revenue surged 24% from the prior year, signaling strong growth momentum. The organization ran a surplus of $718K, a strong 29% operating margin.
TO IMPROVE GLOBAL HEALTH BY ADVANCING THE FRONTIERS OF CLINICAL PHARMACOLOGY. VISION: TO BE THE PREMIER EDUCATIONAL AND SCIENTIFIC NETWORK OF CLINICAL PHARMACOLOGY PROFESSIONALS IN ALL STAGES OF CAREER DEVELOPMENT AND PRACTICE AREAS. THE AMERICAN COLLEGE OF CLINICAL PHARMACOLOGY (ACCP) AIMS TO ADVANCE THE SCIENCE OF CLINICAL PHARMACOLOGY IN ALL ITS PHASES AND TO ENGAGE IN EDUCATIONAL EFFORTS IN THE INTEREST OF MEMBERS, THE CLINICAL PHARMACOLOGY COMMUNITY, AND THE PUBLIC. THIS ASPIRATION IS TO BE ATTAINED IN A MANNER CONSISTENT WITH THE HIGHEST ETHICAL AND SCIENTIFIC STANDARDS.
TO ENHANCE THE KNOWLEDGE, SKILLS AND PROFESSIONAL PRACTICE OF PHYSICIANS, SCIENTISTS, PHARMACISTS AND OTHER HEALTHCARE PROFESSIONALS WHO ARE INVOLVED IN DRUG DEVELOPMENT AND THE EVALUATION AND/OR...
TO ENHANCE THE KNOWLEDGE, SKILLS AND PROFESSIONAL PRACTICE OF PHYSICIANS, SCIENTISTS, PHARMACISTS AND OTHER HEALTHCARE PROFESSIONALS WHO ARE INVOLVED IN DRUG DEVELOPMENT AND THE EVALUATION AND/OR TREATMENT OF PATIENTS. THE EDUCATION PROGRAM IS DESIGNED TO HELP PHYSICIANS, SCIENTISTS, PHARMACISTS AND OTHER HEALTHCARE PROFESSIONALS FOCUS ON QUALITY IMPROVEMENT AND PRACTICE EVIDENCE-BASED MEDICINE IN THE DEVELOPMENT AND EVALUATION OF PHARMACEUTICALS AND BIOLOGICS AND THE DELIVERY OF PATIENT-CENTERED CARE.
PUBLICATION OF "THE JOURNAL OF CLINICAL PHARMACOLOGY AND "CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT" OF HIGH-QUALITY CLINICAL PHARMACOLOGY STUDIES IN DRUG DEVELOPMENT WHICH ARE PRIMARILY (BUT NOT...
PUBLICATION OF "THE JOURNAL OF CLINICAL PHARMACOLOGY AND "CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT" OF HIGH-QUALITY CLINICAL PHARMACOLOGY STUDIES IN DRUG DEVELOPMENT WHICH ARE PRIMARILY (BUT NOT EXCLUSIVELY) PERFORMED IN EARLY DEVELOPMENT PHASES IN HEALTHY SUBJECTS.
PROMOTE AWARENESS OF AND PROVIDE SERVICES TO THE PROFESSION OFCLINICAL PHARMACOLOGY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $2,519,558 | $2,039,332 | +0.2% |
| Expenses | $1,801,421 | $1,746,202 | +0.0% |
| Net Income | $718,137 | $293,130 | +1.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DONALD E MAGER PHARMD PHD FCP | (OUTGOING) IMMEDIATE PAST PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| DIONNA GREEN MD | IMMEDIATE PAST PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| VIKRAM ARYA PHD | COUNCILOR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| OLIVER GRUNDMANN PHD | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| NAVI GOYAL PHD | PRESIDENT ELECT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MYONG-JIN KIM PHARMD | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| CRAIG HENDRIX MD | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| OTITO IWUCHUKWU PHD | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| CATHERIJNE KNIBBE PHARMD PHD | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| ARUN RAM MD | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| PETER WIERNIK MD | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW B DUFEK PHD | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| JEAN-MICHEL GRIES | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| MARK ROGGE | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| NEERAJ GUPTA | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| VIJAY UPRETI | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| DIANE R MOULD | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| AMIT PAI | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| YAN XU | REGENT | 1.00 |
Director
|
$0 | $0 | $0 |
| KRISTA L LEVY | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$198,891 | $29,503 | $228,394 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $2,519,558 | $1,801,421 | $9,876,302 | $718,137 |
| 2023 | $2,039,332 | $1,746,202 | $9,039,685 | $293,130 |
| 2022 | $1,871,264 | $1,510,549 | $8,134,708 | $360,715 |
| 2021 | $1,829,603 | $1,213,589 | $9,164,474 | $616,014 |
| 2020 | $1,552,886 | $1,129,636 | $8,213,746 | $423,250 |
| 2019 | $1,627,298 | $1,560,040 | $7,446,362 | $67,258 |
| 2018 | $1,653,359 | $1,309,135 | $6,456,489 | $344,224 |
Compare AMERICAN COLLEGE OF CLINICAL PHARMACOLOGY INC with other nonprofits in Virginia and across the country.